https://www.selleckchem.com/products/cc-930.html
The ORH group had a significantly superior OS (HR = 1.977, 95%CI 1.077-3.626, P = 0.028) and PFS (HR = 1.811, 95%CI 1.046-3.134, P = 0.034) compared with the LRH group after PS-IPTW analysis. Furthermore, in patients with no high and intermediate risks, difference of the OS (HR = 1.386, 95%CI 0.287-6.69, P = 0.684) and PFS (HR = 1.524, 95%CI 0.363-6.396, P = 0.565) rates between the two groups were with no statistical meaning. Outcomes of this retrospective cohort study were in compliance with indications for ORH recommended by the Natio
Like
Comment
Share
